Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines

被引:52
作者
Perego, P
Righetti, SC
Supino, R
Delia, D
Caserini, C
Carenini, N
Bedogne, B
Broome, E
Krajewski, S
Reed, JC
Zunino, F
机构
[1] Ist Nazl Studio & Cura Tumori, Div Expt Oncol B, I-20133 Milan, Italy
[2] Ist Nazl Studio & Cura Tumori, Div Expt Oncol A, I-20133 Milan, Italy
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Burnham Inst, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
apoptosis; bcl-2; cisplatin resistance; p53;
D O I
10.1023/A:1026442716000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since apoptosis is the primary made of cell death induced by cisplatin, the role of apoptosis acid apoptosis-related gene products in cisplatin resistance was Investigated in four human cisplatin-resistant cell lines of different tumour type. A common feature of the resistant sublines was a reduced susceptibility to drug-induced apoptosis compared to parental sensitive lines. Loss of wild-type p53 function was not a general event associated with the development of drug resistance. an increased bcl-2 expression was found in resistant cells characterized by mutant p53 (A431/Pt and IGROV-1?/Pt), whereas in osteosarcoma (U2-PS/Pt) and in ovarian carcinoma (A2780/CP) cells with wildtype p53, bcl-2 levels were markedly reduced. U2-OS/Pt cells had a 16-fold increase In the level of Bcl-x(L) protein, Stable transfection of CIP-CIS cells with bcl-x(L) cDNA conferred a low Level of drug resistance io cisplatin, suggesting that overexpression of this gene contributes to the cisplatin-resistant phenotype of this osteosarcoma cell system. in conclusion, these observations suggest a variable contribution of apoptosis-related genes to cisplatin resistance depending on the biological background of the cell system and presumably reflecting different pathways of apoptosis.
引用
收藏
页码:540 / 548
页数:9
相关论文
共 40 条
[11]   Apoptosis and chemotherapy resistance [J].
Hickman, JA .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :921-926
[12]   APOPTOSIS INDUCED BY ANTICANCER DRUGS [J].
HICKMAN, JA .
CANCER AND METASTASIS REVIEWS, 1992, 11 (02) :121-139
[13]  
KAMESAKI S, 1993, CANCER RES, V53, P4251
[14]   MODULATION OF APOPTOSIS BY THE WIDELY DISTRIBUTED BCL-2 HOMOLOG BAK [J].
KIEFER, MC ;
BRAUER, MJ ;
POWERS, VC ;
WU, JJ ;
UMANSKY, SR ;
TOMEI, LD ;
BARR, PJ .
NATURE, 1995, 374 (6524) :736-739
[15]  
KORSMEYER SJ, 1992, BLOOD, V80, P879
[16]   MCL1, A GENE EXPRESSED IN PROGRAMMED MYELOID CELL-DIFFERENTIATION, HAS SEQUENCE SIMILARITY TO BCL2 [J].
KOZOPAS, KM ;
YANG, T ;
BUCHAN, HL ;
ZHOU, P ;
CRAIG, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3516-3520
[17]  
KRAJEWSKI S, 1994, AM J PATHOL, V145, P515
[18]  
Krajewski S, 1996, CANCER RES, V56, P2849
[19]  
KRAJEWSKI S, 1995, CANCER RES, V55, P4471
[20]  
KRAJEWSKI S, 1995, AM J PATHOL, V146, P1309